Laporan Laba Rugi (TTM)
Laporan Laba Rugi Autolus Therapeutics plc - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 2 | 2 | 3 | 3 | 2 | 2 | 1 | 3 | 6 | 7 | 7 | 6 | 2 | 10 | 10 | 10 | 10 | 9 | 30 |
| Change (%) | 5.86 | -4.02 | 82.14 | -14.81 | -8.77 | -4.42 | -73.87 | 366.49 | 134.25 | 17.70 | 0.00 | -26.22 | -69.26 | 518.20 | 0.00 | -3.87 | 0.29 | -10.96 | 232.19 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 126 | 135 | 134 | 135 | 134 | 111 | 138 | 144 | 149 | 117 | 111 | 106 | 13 | 122 | 126 | 63 | 120 | 141 | 155 | 184 |
| Change (%) | 7.46 | -0.41 | 0.60 | -0.93 | -17.21 | 24.52 | 4.41 | 3.71 | -21.47 | -5.60 | -4.50 | -88.16 | 876.17 | 2.68 | -49.69 | 89.97 | 17.47 | 9.94 | 18.97 | |
| % of Revenue | 7,748.64 | 7,865.19 | 8,161.12 | 4,507.51 | 5,242.05 | 4,757.04 | 6,197.62 | 24,759.79 | 5,504.27 | 1,845.19 | 1,479.82 | 1,413.29 | 226.87 | 7,203.42 | 1,196.50 | 602.00 | 1,189.65 | 1,393.48 | 1,720.50 | 616.17 |
| Gross Operating Profit | -124 | -133 | -133 | -132 | -131 | -109 | -136 | -144 | -147 | -111 | -103 | -98 | -7 | -121 | -115 | -53 | -110 | -131 | -146 | -155 |
| Change (%) | 7.48 | -0.37 | -0.41 | -0.61 | -17.38 | 25.15 | 5.69 | 2.23 | -24.35 | -6.94 | -4.82 | -92.87 | 1,621.36 | -4.57 | -54.22 | 108.67 | 19.05 | 11.55 | 5.81 | |
| % of Revenue | -7,648.64 | -7,765.19 | -8,061.12 | -4,407.51 | -5,142.05 | -4,657.04 | -6,097.62 | -24,659.79 | -5,404.27 | -1,745.19 | -1,379.82 | -1,313.29 | -126.87 | -7,103.42 | -1,096.50 | -502.00 | -1,089.65 | -1,293.48 | -1,620.50 | -516.17 |
| SG&A | 36 | 35 | 36 | 35 | 33 | 32 | 31 | 32 | 32 | 32 | 33 | 36 | 38 | 55 | 64 | 75 | 91 | 110 | 121 | 130 |
| Change (%) | -2.55 | 3.21 | -3.52 | -4.43 | -4.25 | -2.36 | 3.32 | -0.21 | -0.56 | 4.07 | 8.59 | 6.60 | 42.89 | 16.20 | 16.90 | 22.42 | 20.35 | 10.33 | 6.90 | |
| % of Revenue | 2,215.25 | 2,039.18 | 2,192.95 | 1,161.57 | 1,303.05 | 1,367.60 | 1,397.13 | 5,523.37 | 1,181.51 | 501.56 | 443.44 | 481.55 | 695.80 | 3,233.92 | 607.84 | 710.55 | 904.82 | 1,085.86 | 1,345.53 | 432.98 |
| R&D | 88 | 66 | 17 | -14 | ||||||||||||||||
| Change (%) | -74.26 | |||||||||||||||||||
| % of Revenue | 1,592.54 | 626.70 | 167.81 | -47.26 | ||||||||||||||||
| OpEx | 161 | 170 | 170 | 170 | 167 | 143 | 169 | 176 | 182 | 149 | 144 | 142 | 139 | 177 | 189 | 204 | 228 | 251 | 276 | 300 |
| Change (%) | 5.23 | 0.33 | -0.28 | -1.65 | -14.63 | 18.52 | 4.21 | 2.99 | -17.78 | -3.54 | -1.48 | -2.07 | 27.58 | 6.87 | 7.48 | 12.15 | 9.91 | 10.11 | 8.55 | |
| % of Revenue | 9,963.89 | 9,904.37 | 10,354.07 | 5,669.08 | 6,545.11 | 6,124.64 | 7,594.75 | 30,283.16 | 6,685.78 | 2,346.75 | 1,923.26 | 1,894.84 | 2,515.21 | 10,437.34 | 1,804.34 | 1,939.25 | 2,262.28 | 2,479.34 | 3,066.03 | 1,001.89 |
| Operating Income | -160 | -168 | -169 | -167 | -165 | -140 | -167 | -176 | -179 | -143 | -136 | -134 | -133 | -176 | -179 | -193 | -218 | -241 | -267 | -270 |
| Change (%) | 5.23 | 0.38 | -1.08 | -1.41 | -14.72 | 18.90 | 5.25 | 1.79 | -20.08 | -4.48 | -1.56 | -0.72 | 31.59 | 1.92 | 7.92 | 13.02 | 10.35 | 11.00 | 1.01 | |
| % of Revenue | -9,863.89 | -9,804.37 | -10,254.07 | -5,569.08 | -6,445.11 | -6,024.64 | -7,494.75 | -30,183.16 | -6,585.78 | -2,246.75 | -1,823.26 | -1,794.84 | -2,415.21 | -10,337.34 | -1,704.34 | -1,839.25 | -2,162.28 | -2,379.34 | -2,966.03 | -901.89 |
| Interest Expense | -1 | -3 | -5 | -7 | -9 | -12 | -15 | -18 | -45 | -59 | -54 | -59 | -9 | -0 | -12 | |||||
| Change (%) | 161.99 | 62.49 | 39.31 | 35.89 | 34.98 | 26.71 | 20.78 | 144.98 | 31.87 | -9.62 | 10.56 | -84.35 | -98.19 | 6,780.95 | ||||||
| % of Revenue | -47.42 | -130.00 | -808.25 | -241.36 | -140.02 | -160.57 | -203.46 | -333.08 | -2,654.12 | -566.17 | -511.72 | -588.51 | -91.84 | -1.86 | -38.62 | |||||
| Net Income | -140 | -142 | -145 | -147 | -143 | -142 | -146 | -155 | -164 | -149 | -152 | -155 | -158 | -208 | -221 | -234 | -270 | -221 | -238 | -228 |
| Change (%) | 1.37 | 2.39 | 0.78 | -2.27 | -0.83 | 2.67 | 6.09 | 5.67 | -9.00 | 1.85 | 2.30 | 1.99 | 31.75 | 6.18 | 5.75 | 15.49 | -18.34 | 7.92 | -4.35 | |
| % of Revenue | -8,652.90 | -8,285.36 | -8,838.82 | -4,890.46 | -5,610.45 | -6,098.54 | -6,551.06 | -26,593.81 | -6,024.09 | -2,340.24 | -2,024.95 | -2,071.63 | -2,863.72 | -12,272.26 | -2,107.86 | -2,229.04 | -2,677.90 | -2,180.45 | -2,642.69 | -760.94 |
Source: Capital IQ
